Common Questions

The Venture Architecture Diagnostic (VAD) is a 14-work-day corporate venture diagnostic, led personally by Thomas Calvert, that produces one of four evidence-backed verdicts on a corporate venture idea before the organization commits Stage 2 capital. It is a structured external verdict — not an internal opinion, and not a framework workshop.

GO — core assumptions hold and structural fit is confirmed; proceed to Stage 2. PIVOT — promising signal but the wrong configuration; specific pivot conditions are named. WRONG COMPANY — the idea has merit but not in this host organization; a licensing, partnership, or spin-out path is identified. NO-GO — the hypothesis does not hold and capital is preserved. Every verdict arrives with a named forward path.

The base Venture Architecture Diagnostic runs 14 work days from kickoff to verdict delivery. An optional tier adds 60 days of post-sprint validation support through the Stage 2 window.

A Quick Scan is $2,500 over 3 business days. The Base Sprint is $15,000–$20,000. Sprint plus Executive Presentation is $20,000–$25,000. Sprint plus 60-Day Validation is $35,000–$45,000. Two further tiers support specific situations: a Re-Sprint following a PIVOT reframe is $10,000–$15,000 over 7 work days, and Stage 2 Validation Advisory is $5,000 per month for post-GO execution support.

Every engagement is led personally by Thomas Calvert — no junior analysts and no delegated delivery. The analysis is AI-augmented to handle analytical volume, but Thomas is the sole author of the verdict.

The sprint runs eight analytical streams in parallel: structural fit (RPP), market intelligence, unit economics and financial modeling, assumption extraction and risk mapping, an adversarial bias audit, stakeholder interview analysis, validation experiment design, and hypothesis stress testing. These feed a composite scoring model and a verdict decision matrix. The output is not a deck of options — it is one of four verdicts, supported by a complete evidence trail and a named forward path.

RPP stands for Resources, Processes, and Priorities — the structural relationship between what a venture requires and what its host organization is actually built to do. The framework is grounded in established disruption research (Christensen and Raynor; Harvard Business School case material). The firm’s position is that structure, not idea quality, is the single most predictive variable in corporate venture outcomes. A strong commercial case cannot override a structurally disqualifying fit — which is precisely the failure mode the WRONG COMPANY verdict exists to catch.

Market size is rebuilt from the bottom up — addressable buyers multiplied by realistic pricing — rather than taken as a top-down share of an analyst’s total addressable market. Every financial input is rebased from client-generated assumptions to evidence-backed ones, producing a three-scenario model: optimistic, base case, and bear case. The base-case numbers, not the optimistic ones, are what go to the CFO.

It is the VAD’s formal mechanism for counteracting institutional optimism — a structured adversarial analysis that surfaces the assumptions a venture depends on, builds the strongest possible case that the most load-bearing ones are wrong, and stress-tests the financials against documented base rates. The premise is that the people closest to a venture are the least able to challenge it, because they have spent months anchoring on the optimistic reading. The audit is designed to do what an internal team structurally cannot.

Not because the team lacks capability — because of where they sit. The people who understand a venture well enough to challenge it are usually the same people who have advocated for it long enough to anchor on the best-case interpretation. That gap is structural, not a skills problem, and it cannot be closed from inside the organization. An external diagnostic supplies the one thing an internal review cannot: independence from the outcome.

Three things, and the firm is deliberate about not overstating any of them. First, method over opinion — every verdict traces to eight analytical streams, a composite score, and an explicit risk-confidence discount, rather than intuition. Second, calibration against a documented corpus: within the firm’s Pattern Library of catalogued venture cases, a structural-fit score of 2 or below is associated with a NO-GO or WRONG COMPANY outcome in 96% of cases (N=128; Wilson confidence-interval lower bound approximately 91%). This is a retrospective calibration finding — it demonstrates that the structural signal is strong; it is not a success rate for live engagements. Third, named limitations: the methodology discloses where it is less reliable before any engagement is signed.

Every engagement includes a disclosed limitations statement. The VAD’s predictive reliability is reduced in five contexts: two-sided marketplace ventures, where network-effect dynamics are underweighted; regulatory-gated businesses, where timeline assumptions require specialist verification; M&A-driven ventures, where parent-integration dynamics fall outside the structural scoring model; deep-tech or pre-commercial ventures, where technology-readiness assumptions sit outside the standard rubric; and radical business-model innovation in mature markets, where pattern matching biases toward historical cases. Disclosing these is treated as a feature, not a hedge.

No. The VAD runs on a structured toolkit of purpose-built tools deployed across every analytical stream, including cross-checking outputs against an independent model. The AI accelerates the analysis; it does not author the conclusion. Roughly 40% of the work — live client engagement, structural scoring judgment, contextual pattern recognition, and final synthesis — is non-substitutable and performed personally by Thomas. Thomas authors every verdict.

Mid-market companies — roughly $200M to $2B in annual revenue — that operate an active corporate venture or incubation function and are weighing whether to commit Stage 2 capital to a specific idea. It is most useful at the decision point before significant build spend, when a wrong answer is still inexpensive to discover.

The verdict is the inflection point, not the end. The firm helps deliver the verdict internally — to the CFO, leadership, and the board — with the evidence base and framing built in, because most verdicts die in translation. A PIVOT comes with named conditions and a validation agenda; a WRONG COMPANY comes with a structured alternative (license, partner, or spin-out); a GO can carry optional Stage 2 advisory support. Every outcome keeps the venture lead positioned forward, not corrected backward.